Activation of bone morphogenetic protein type 1A receptors (BMPR1A) by THR184 halts the progression of the left ventricular remodelling under pressure overload

30 April 2022 (16:20 - 17:00)
Organised by: Logo
Congress Presentation Part of: Moderated poster 4 AWARD Drugs, Drug Targets CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science